Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Net Cash Flow (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Net Cash Flow for 5 consecutive years, with $16.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Cash Flow rose 255.26% year-over-year to $16.2 million, compared with a TTM value of $32.8 million through Sep 2025, up 443.51%, and an annual FY2024 reading of $3.5 million, up 196.76% over the prior year.
  • Net Cash Flow was $16.2 million for Q3 2025 at Lucid Diagnostics, up from $5.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $53.6 million in Q4 2021 and bottomed at -$15.2 million in Q2 2022.
  • Average Net Cash Flow over 5 years is $2.5 million, with a median of -$24000.0 recorded in 2021.
  • The sharpest move saw Net Cash Flow plummeted 23804.17% in 2022, then surged 3829.8% in 2025.
  • Year by year, Net Cash Flow stood at $53.6 million in 2021, then tumbled by 108.32% to -$4.5 million in 2022, then fell by 15.56% to -$5.2 million in 2023, then skyrocketed by 252.68% to $7.9 million in 2024, then skyrocketed by 105.81% to $16.2 million in 2025.
  • Business Quant data shows Net Cash Flow for LUCD at $16.2 million in Q3 2025, $5.9 million in Q2 2025, and $2.8 million in Q1 2025.